Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status
Multicentre randomized trials have shown that allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective strategy for preventing relapse in patients in first complete remission (CR) of acute myeloblastic leukemia (AML), offering up to 50% disease-free survival. However in adult...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
2005
|
| Materias: | |
| Acceso en línea: | http://eprints.uanl.mx/27802/1/492.pdf |